'Walking distance' test an accurate indicator of disease severity in patients with COPD
Monday, May 16, 2011 - 04:30
in Health & Medicine
The six-minute walking distance test (6MWD), a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease (COPD), according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.